Bridgeway Capital Management, LLC Nrx Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.47 $9,880 - $17,860	-38,000 Reduced 23.65%	122,700 $56,000
Q2 2023 Aug 14, 2023	SELL	$0.46 - $0.89 $32,200 - $62,300	-70,000 Reduced 30.34%	160,700 $77,000
Q1 2023 May 15, 2023	BUY	$0.66 - $1.4 $34,320 - $72,800	52,000 Added 29.1%	230,700 $152,000
Q4 2022 Feb 14, 2023	BUY	$0.79 - $9.19 $19,750 - $229,750	25,000 Added 16.27%	178,700 $198,000
Q2 2022 Aug 15, 2022	BUY	$0.51 - $2.42 $78,387 - $371,954	153,700 New	153,700 $92,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $111M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.